CAPTRUST Financial Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
CAPTRUST Financial Advisors's NEO Position: Q2 2026 in Review
CAPTRUST Financial Advisors increased its NeoGenomics (NEO) stake by 135% in Q2 2026, buying an estimated $150K and bringing the position to 27,149 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.
CAPTRUST Financial Advisors first reported a position in NEO in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.19M in Q2 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- CAPTRUST Financial Advisors held 27,149 shares of NeoGenomics worth $396K as of Q2 2026.
- CAPTRUST Financial Advisors bought 15,591 NeoGenomics shares in Q2 2026, an estimated $150K.
- NeoGenomics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2352 holding.
- CAPTRUST Financial Advisors first reported a position in NeoGenomics in Q2 2019 and has held it in 17 quarters since.
- CAPTRUST Financial Advisors's NeoGenomics position peaked at $1.19M in Q2 2023.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.